SEC Filing Update: #APGE Apogee Therapeutics, Inc. : $135.11

Sector: Healthcare | YTD: 🔼+ 78.29% The SEC disclosed Today (08-SEP-2026) that VENROCK HEALTHCARE CAPITAL PARTNERS III, L.P. has DECREASED #APGE Shares by -100.00% 🔴 * Previous Holdings: 3.89M Shares * Current Holdings: 0.00 Shares * Decrease -3.89M * Decreased (%)-100.00% * Ownership: 0.0% https://www.thinksabio.com/reports/isr/APGE The quarterly average prices of #APGE: Q3 2025: $38.17 Q4 2025: $62.79 Q1 2026: $72.64 Q2 2026: $90.12 📈 Stay ahead of institutional buy/sell moves — Sign up free at ThinkSabio: Sign Up Free → 🐦 See this update on X: https://x.com/Thinksabio/status/2097440055056798089 VENROCK HEALTHCARE CAPITAL PARTNERS III, L.P. sold all 3,887,478 shares it held in Apoge Inc., reducing its ownership stake from a previous position to 0 shares and 0.0% ownership in the healthcare sector company.